132054-64-9 Usage
Uses
Used in Organic Synthesis:
(1S,5R,Z)-5-(tert-butyldiMethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-Methylenecyclohexanol is used as a building block in organic synthesis for the creation of more complex molecules and structures.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (1S,5R,Z)-5-(tert-butyldiMethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-Methylenecyclohexanol serves as a potential candidate for the development of new drugs and pharmaceuticals due to its unique structure and functional groups.
Used in Chemical Research:
(1S,5R,Z)-5-(tert-butyldiMethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-Methylenecyclohexanol is utilized in chemical research to study its properties, reactivity, and potential applications in various chemical processes.
Used in Specialty Chemicals Industry:
(1S,5R,Z)-5-(tert-butyldiMethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-Methylenecyclohexanol is also used in the specialty chemicals industry for the development of high-value products with specific applications, such as advanced materials, coatings, or catalysts.
Check Digit Verification of cas no
The CAS Registry Mumber 132054-64-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,0,5 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 132054-64:
(8*1)+(7*3)+(6*2)+(5*0)+(4*5)+(3*4)+(2*6)+(1*4)=89
89 % 10 = 9
So 132054-64-9 is a valid CAS Registry Number.
132054-64-9Relevant academic research and scientific papers
1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: Synthesis and molecular mechanism of action
Ray, Rahul,Lambert, James R.
, p. 2537 - 2540 (2011/06/11)
Synthesis of 1α,25-dihydroxyvitamin D3-3β- bromoacetate (1,25(OH)2D3-3-BE), a potential anti-cancer agent is presented. We also report that mechanism of action of 1,25(OH) 2D3-3-BE may involve reducti
Rational Design of Vitamin D3 Analogues Which Selectively Restore Activity to a Vitamin D Receptor Mutant Associated with Rickets
Swann, Steve L.,Bergh, Joel J.,Farach-Carson, M. Cindy,Koh, John T.
, p. 3863 - 3866 (2007/10/03)
(Matrix Presented) Vitamin D3-resistant rickets (VDRR) is associated with mutations to the Vitamin D receptor (VDR) which effect ligand-dependent transactivation. Some VDRR associated mutants directly disrupt ligand binding. Using the reported
